A Phase II Trial of Huperzine a in Mild to Moderate Alzheimer Disease
Neurology - United States
doi 10.1212/wnl.0b013e318216eb7b
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 18, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)